Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Marco Massari and Stefania Spila Alegiani.
Marco Massari
Connection Strength
0.655
Stefania Spila Alegiani
  1. Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy. Rheumatology (Oxford). 2021 10 09; 60(SI):SI25-SI36.
    View in: PubMed
    Score: 0.243
  2. Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-CoV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study. Vaccines (Basel). 2021 Jul 01; 9(7).
    View in: PubMed
    Score: 0.238
  3. Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021. Euro Surveill. 2021 Jun; 26(25).
    View in: PubMed
    Score: 0.059
  4. Survival of Hospitalized COVID-19 Patients in Northern Italy: A Population-Based Cohort Study by the ITA-COVID-19 Network. Clin Epidemiol. 2020; 12:1337-1346.
    View in: PubMed
    Score: 0.057
  5. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients. Drug Saf. 2020 12; 43(12):1297-1308.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.